Morgan Stanley Call 14 DVAX 21.06.../ DE000ME76N20 /
| 2024-05-24 6:07:12 PM | Chg.0.000 | Bid10:00:32 PM | Ask10:00:32 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.001EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
Dynavax Technologies... | 14.00 USD | 2024-06-21 | Call |
GlobeNewswire
05-15
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
03-06
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Va...
GlobeNewswire
01-08
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical O...
GlobeNewswire
2022-03-01
Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
2022-02-25
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate V...
GlobeNewswire
2022-01-25
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
GlobeNewswire
2022-01-19
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
GlobeNewswire
2022-01-06
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vac...
GlobeNewswire
2021-12-23
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site
GlobeNewswire
2021-12-16
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Cand...
GlobeNewswire
2021-12-08
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
GlobeNewswire
2021-12-02
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine ...
GlobeNewswire
2021-11-29
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2...
GlobeNewswire
2021-11-23
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
2021-11-10
Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million D...
GlobeNewswire
2021-11-04
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire
2021-11-02
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
GlobeNewswire
2021-10-18
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2...
GlobeNewswire
2021-09-23
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
GlobeNewswire
2021-09-14
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 V...
GlobeNewswire
2021-09-13
Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government
